https://www.selleckchem.com/pr....oducts/4-phenylbutyr
The indications for prehospital hydroxocobalamin are not well defined. The aim of this study was to evaluate prehospital signs and symptoms in patients who received hydroxocobalamin to improve future use. In this retrospective study, all patients who received prehospital Hydroxocobalamin at a tertiary care burn center from December 2012 to March 2018 were reviewed. Each case was evaluated for evidence of suspected cyanide toxicity hypotension, syncope, CNS depression/altered mentation, seizures, respiratory or cardia
Curtir
Comentario
Compartilhar
